RECLAST (zoledronic acid in mannitol and water for injection)


Drug overview for RECLAST (zoledronic acid in mannitol and water for injection):

Generic name: zoledronic acid in mannitol and water for injection (ZOLE-eh-dron-ick)
Drug class: Hypercalcemia Agents
Therapeutic class: Endocrine

Zoledronic acid, a synthetic imidazole bisphosphonate analog of pyrophosphate, is a bone resorption inhibitor.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • RECLAST 5 MG/100 ML SOLUTION
    RECLAST 5 MG/100 ML SOLUTION
The following indications for RECLAST (zoledronic acid in mannitol and water for injection) have been approved by the FDA:

Indications:
Glucocorticoid-induced osteoporosis
Osteoporosis in male patient
Osteoporosis in postmenopausal woman at high risk for fracture
Paget's disease of bone
Post-menopausal osteoporosis prevention
Prevention of glucocorticoid-induced osteoporosis


Professional Synonyms:
Glucocorticoid hormone-induced osteoporosis
Glucocorticoid induced osteoporosis
Glucocorticoid-induced osteoporosis prophylaxis
Glycocorticoid-induced osteoporosis
Osteitis deformans
Osteoporosis in men
Postmenopausal osteoporosis in woman with high fracture risk
Postmenopausal osteoporosis prophylaxis
Postmenopausal osteoporosis with high fracture risk